TORONTO--(BUSINESS WIRE)--Highland Therapeutics Inc. (“Highland”), a pharmaceutical company, today announced that its wholly owned subsidiary, Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), will host a poster presentation highlighting Phase III clinical data at the upcoming American Psychiatric Association (APA) 168th Annual Meeting in Toronto, Canada.
Help employers find you! Check out all the jobs and post your resume.
